Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 3;5(10):e2237908.
doi: 10.1001/jamanetworkopen.2022.37908.

Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study

Affiliations

Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study

Emilia A Hermann et al. JAMA Netw Open. .

Erratum in

  • Error in Figure and Discussion.
    [No authors listed] [No authors listed] JAMA Netw Open. 2022 Nov 1;5(11):e2247057. doi: 10.1001/jamanetworkopen.2022.47057. JAMA Netw Open. 2022. PMID: 36441556 Free PMC article. No abstract available.
No abstract available

Plain language summary

This cohort study examines the association of self-reported postvaccination symptoms with anti–SARS-CoV-2 antibody response among Framingham Heart Study participants contributing to the Collaborative Cohort of Cohorts for COVID-19 Research study.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Balte reported receiving grants from the National Institutes of Health during the conduct of the study. Dr Oelsner reported receiving grants from the National Heart, Lung, and Blood Institute during the conduct of the study and outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Association of Self-reported Symptoms After SARS-CoV-2 Messenger RNA Vaccination With Continuous Log-Transformed Values for Anti-Spike IgG Antibodies Among 928 Fully Vaccinated Framingham Heart Study Participants, February 2021 to January 2022
Effect estimates for self-reported symptoms compared with no symptoms with 95% CIs. Plus signs indicate that those factors were sequentially added to the model. aMedical factors include body mass index, smoking status, diabetes, hypertension, coronary heart disease, heart failure, stroke or transient ischemic attack, and estimated glomerular filtration rate.

Similar articles

Cited by

References

    1. Bauernfeind S, Salzberger B, Hitzenbichler F, et al. . Association between reactogenicity and immunogenicity after vaccination with BNT162b2. Vaccines (Basel). 2021;9(10):1089. doi:10.3390/vaccines9101089 - DOI - PMC - PubMed
    1. Held J, Esse J, Tascilar K, et al. . Reactogenicity correlates only weakly with humoral immunogenicity after COVID-19 vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines (Basel). 2021;9(10):1063. doi:10.3390/vaccines9101063 - DOI - PMC - PubMed
    1. Hwang YH, Song KH, Choi Y, et al. . Can reactogenicity predict immunogenicity after COVID-19 vaccination? Korean J Intern Med. 2021;36(6):1486-1491. doi:10.3904/kjim.2021.210 - DOI - PMC - PubMed
    1. Oelsner EC, Krishnaswamy A, Balte PP, et al. ; for the C4R Investigators . Collaborative cohort of cohorts for COVID-19 research (C4R) study: study design. Am J Epidemiol. 2022;191(7):1153-1173. doi:10.1093/aje/kwac032 - DOI - PMC - PubMed
    1. Styer LM, Hoen R, Rock J, et al. . High-throughput multiplex SARS-CoV-2 IgG microsphere immunoassay for dried blood spots: a public health strategy for enhanced serosurvey capacity. Microbiol Spectr. 2021;9(1):e0013421. doi:10.1128/Spectrum.00134-21 - DOI - PMC - PubMed

Publication types